Chairman:
Kyungsoo Park, Yonsei University, Korea

International Advisory Board:
Pascal Girard, INSERM - EA 3738 Univ Lyon I, France
Don R. Stanski, Novartis Pharmaceuticals, USA
Tom Ludden, GloboMax, a Division of ICON, USA
Jean-Louis Steimer, Novartis Pharmaceuticals, Switzerland
Atsunori Kaibara, Astellas Pharmaceutical Corp., Japan

Local Advisory Board:
Kyung Hwan Kim, Yonsei University, Korea
Sang Goo Shin, Seoul National University, Korea
Hyung-Keun Roh, Inha University, Korea
Min Soo Park, Yonsei University, Korea
Jae-Gook Shin, Inje University, Korea
In-Jin Jang, Seoul National University, Korea
Dong-Seok Yim, Catholic University, Korea
Kyun-Seop Bae, University of Ulsan, Korea
Hyeong-Seok Lim, National Cancer Center, Korea
Young-Ran Yoon, Gyeongbuk National University, Korea
Yil-Seob Lee, GSK Korea, Korea
Woo-Ick Jang, MSD Korea, Korea
Won-Sik Lee, Pfizer Korea, Korea

Supporting Organizations:
Ministry of Health & Welfare
Korea Healthy Industry Development Institute
Seoul Metropolitan Government
Korean Society for Clinical Pharmacology and Therapeutics
Korean Society of Pharmaceutical Medicine
Korean Association of Clinical Trials Centers